Aquestive Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Warren, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Aquestive Therapeutics, Inc. has filed 658 SEC EDGAR filings since 14 May 2007

SEC filing history

Showing 476-500 of 651 matching filings.

Per page
25
Current page
20
4

PRIMARY DOCUMENT

Filing date
18 Mar 2020
Reporting date
16 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Mar 2020
Reporting date
16 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Mar 2020
Reporting date
16 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Mar 2020
Reporting date
16 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Mar 2020
Reporting date
16 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Mar 2020
Reporting date
16 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-233716

424B5

Filing date
12 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38599

8-K

Filing date
11 Mar 2020
Reporting date
11 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2020
Reporting date
29 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Mar 2020
Reporting date
29 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
26 Feb 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
26 Feb 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
26 Feb 2020
Reporting date
30 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
26 Feb 2020
Reporting date
30 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90885

SC 13G/A

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90885

AQUESTIVE THERAPEUTICS, INC. SCHEDULE 13G, AMENDMENT NO. 1

Filing date
12 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38599

8-K

Filing date
10 Feb 2020
Reporting date
10 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38599

8-K

Filing date
06 Feb 2020
Reporting date
06 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38599

8-K

Filing date
13 Jan 2020
Reporting date
12 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38599

8-K

Filing date
10 Jan 2020
Reporting date
10 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Jan 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Jan 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38599

8-K

Filing date
16 Dec 2019
Reporting date
12 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-233716

424B5

Filing date
16 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .